✦ LIBER ✦

Treatment of heterosexual and homosexual patients with HBeAG positive chronic hepatitis B with low dose interferon alpha (IFN-A)

✍ Scribed by Puzniak, Laura A.; Capitano, Blair; Biswas, Pinaki; Lodise, Thomas P.

Book ID: 122365159
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 72 KB
Volume: 5
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(87)80420-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of interferon and lamivudine

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history

Treatment of decompensated viral hepatit

Treatment of decompensated viral hepatitis B induced liver cirrhosis with low dose interferon alpha (IFN)

✍ Nevens, F.; Goubau, P.; Van Eyken, P.; Desmyter, J.; Desmet, V.; Fevery, J. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Comparison of lamivudine monotherapy wit

Comparison of lamivudine monotherapy with lamivudine plus interferon alpha combination in patients with HBEAG positive chronic hepatitis B

✍ Z. Karasu; G. Ersoz; U. Akarca; F. Gunsar; R. Vardar; Y. Batur 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Interferon alpha2a in combination with l

Interferon alpha2a in combination with lamivudine in the treatment of patients with chronic HbeAg(−) hepatitis B non-responders to interferon monotherapy

✍ Maria Raptopoulou-Gigi; Emanuel Sinakos; Helen Orphanou; Thalia Lalla 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

PG12 DOSE-RESPONSE RELATION OF INTERFERO

PG12 DOSE-RESPONSE RELATION OF INTERFERON-ALPHA IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B: META-ANALYSIS AND META-REGRESSION OF RANDOMIZED TRIALS

✍ X Sun; Y Li; R Zhou 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

OL-015 A pharmacogenomics approach to pr

OL-015 A pharmacogenomics approach to predict the efficacy of HBeAg-positive chronic hepatitis B patients with pegylated interferon treatment

✍ Y.C. Hwang; G.K.K. Lau; J.H. Kao; W.L. Chuang; C.Y. Peng; X.X. Zhang; M. Wan; K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB